The Shared Equipment and Basic Research Laboratory Services Core provides: 1) supervision and maintenance of all shared equipment and service contracts for heavily-used, expensive pieces of equipment such as ultricentrifuges and liquid scintillation counters; 2) centralized supplies, including carbon dioxide liquid nitrogen, dry ice and deionized and distilled water, to Cancer Center laboratories; 3) basic services such as routine maintenance of freezers, balances, microscopes and hoods in individual laboratories; and 4) assessment of need and recommendations for purchases of new shared equipment or services. The Core Facility provides services at three Cancer Center sites: the Norris and Topping Towers, the Cancer Research Laboratories (CRL), and the Smith Research Tower at Children's Hospital Los Angeles (CHLA). The Facility is supervised by Joseph, and services are managed are managed on a daily basis by Bill Taylor, Director of General Services for the Cancer Center. Emil Bogenmann, Ph.D., Associate Professor of Pediatrics and Molecular Microbiology and Immunology, provides additional oversight for shared equipment at the CHLA site. A Users' Committee sets policy and provides strategic direction for the Core.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-27
Application #
6563664
Study Section
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
27
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Vannini, Ivan; Fanini, Francesca; Fabbri, Muller (2018) Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 48:128-133
Veyseh, Maedah; Ricker, Charite; Espenschied, Carin et al. (2018) Secondary Germline Finding in Liquid Biopsy of a Deceased Patient; Case Report and Review of the Literature. Front Oncol 8:259
Bluthenthal, Ricky N; Chu, Daniel; Wenger, Lynn D et al. (2018) Differences in time to injection onset by drug in California: Implications for the emerging heroin epidemic. Drug Alcohol Depend 185:253-259
Sunakawa, Yu; Yang, Dongyun; Cao, Shu et al. (2018) Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer. Clin Colorectal Cancer 17:e741-e749
Skeate, Joseph G; Da Silva, Diane M; Chavez-Juan, Elena et al. (2018) Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response. PLoS One 13:e0191311
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun et al. (2018) Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol 187:366-377
Kiran, Sayee; Jeong, Young Ju; Nelson, Maria E et al. (2018) Are we overtreating intraductal papillomas? J Surg Res 231:387-394
Basso, Virginia; Garcia, Angie; Tran, Dat Q et al. (2018) Fungicidal Potency and Mechanisms of ?-Defensins against Multidrug-Resistant Candida Species. Antimicrob Agents Chemother 62:
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647

Showing the most recent 10 out of 842 publications